Kimberly-Clark está comprando al fabricante de Tylenol, Kenvue, en un acuerdo de efectivo y acciones valorado en aproximadamente 48.700 millones de dólares, creando una enorme empresa de bienes de salud para el consumidor.

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when the Republican state of Texas sued them. The complaint says that the companies didn’t tell people about the possible risks of taking acetaminophen while pregnant.

President Trump's health secretary said Tylenol should be used with caution during pregnancy, but solid data linking it to autism is lacking.

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider.